Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage

A history of antiplatelet medication use better identifies patients at risk for hematoma growth and poor functional outcomes than POC measures of platelet activity after spontaneous ICH.